TL;DR
This paper introduces FERREG, a novel database that comprehensively curates and links data on ferroptosis, a crucial cell death pathway, with disease occurrence, progression, and therapeutic responses. By providing a structured and cross-referenced resource, FERREG aims to accelerate research and drug development in this rapidly evolving field.
What Problem Does This Paper Address?
Ferroptosis, an iron-dependent form of programmed cell death, is increasingly recognized for its significant role in a wide range of diseases, including cancer, aging, and neurodegenerative disorders. While research into ferroptosis has exploded, there's a critical need for a centralized, organized, and interconnected repository of information. Existing databases, like FerrDb and ncFO, offer valuable insights but lack a comprehensive view of how ferroptosis influences disease progression and therapeutic outcomes. Specifically, there's a gap in systematically detailing the molecular mechanisms underlying ferroptosis regulation in various disease contexts and its modulation by drugs. This lack of a unified resource hinders researchers from efficiently exploring the complex interplay between ferroptosis, disease, and treatment, thereby slowing down the development of novel therapeutic strategies.
Methods
The FERREG database was constructed through a systematic literature review of PubMed, focusing on ferroptosis alterations related to disease occurrence, development, and drug response. The core methodology involved:
- Data Curation: Identifying and categorizing ferroptosis targets into "driver," "suppressor," and "marker" based on their roles in the pathway.
- Regulator and Drug Identification: Identifying molecules and genes that regulate these ferroptosis targets.
- Mechanism Elucidation: Explicitly describing the molecular mechanisms underlying each identified regulation.
- Cross-referencing: Linking all collected data to diverse, well-established external databases (e.g., NCBI Gene, UniProt, miRbase, PubChem, TTD, DrugBank, KEGG, ICD). This ensures data consistency and allows users to access more detailed information.
- Data Standardization: Normalizing data naming conventions for targets and regulators, standardizing disease classifications according to the International Classification of Diseases (ICD), and providing external links for drug information.
Datasets
FERREG is a newly developed database that integrates data from a comprehensive literature review. It contains:
- 51 ferroptosis targets: Classified as 34 drivers, 26 suppressors, and 8 markers.
- 718 regulators: Including 471 protein-coding genes, 130 miRNAs, 55 lncRNAs, 47 circRNAs, 14 precursor RNAs, and 1 pseudogene.
- 445 ferroptosis-related drugs: Categorized as small molecules, proteins, and others.
- 158 ferroptosis-related disease responses: Standardized according to the latest International Classification of Disease.
- 802 cell lines: Used in experimental entries for disease response.
Key Insights and Ideas
- Ferroptosis as a Central Hub: The database highlights ferroptosis not just as a cell death mechanism but as a critical node connecting diverse cellular processes to disease pathogenesis and therapeutic response.
- Mechanistic Depth: FERREG goes beyond simple associations, providing explicit descriptions of the molecular mechanisms by which regulators and drugs influence ferroptosis, offering a deeper understanding of disease progression.
- Interconnectedness of Biological Entities: The cross-referencing feature is a key innovation, allowing users to seamlessly navigate between targets, regulators, drugs, and diseases, revealing complex regulatory networks.
- Clinical Relevance: By including drug response data and linking to clinical trial information, FERREG bridges the gap between fundamental research and potential therapeutic applications.
Key Results
The FERREG database is a comprehensive resource containing:
- 51 ferroptosis targets
- 718 regulators
- 445 ferroptosis-related drugs
- 158 ferroptosis-related disease responses
The database provides detailed information on the biological function of targets, their classification as drivers, suppressors, or markers, and their involvement in three key metabolic pathways of ferroptosis: system Xc⁻/GPX4 axis, lipid metabolism, and iron metabolism. It also details regulatory relationships, associated diseases, and drug responses, supported by experimental evidence and mechanistic descriptions.
Limitations and Future Work
The authors acknowledge that ferroptosis is a rapidly evolving field. While FERREG is comprehensive, they plan to continuously update the database to incorporate new findings and expand its scope. Future work will likely focus on:
- Expanding the dataset: Incorporating more targets, regulators, drugs, and disease associations as research progresses.
- Enhancing mechanistic details: Further elucidating complex regulatory pathways and interactions.
- Integrating new data types: Potentially including omics data or clinical trial outcomes to further enrich the resource.
- Improving user interface and analytical tools: To facilitate more advanced data exploration and analysis for researchers.
Summary updated